Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B4JS
|
||||
| Former ID |
DNC008482
|
||||
| Drug Name |
1-(1,3-diphenylpropylidene)thiosemicarbazide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529432] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H17N3S
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCC(=NNC(=S)N)C2=CC=CC=C2
|
||||
| InChI |
1S/C16H17N3S/c17-16(20)19-18-15(14-9-5-2-6-10-14)12-11-13-7-3-1-4-8-13/h1-10H,11-12H2,(H3,17,19,20)/b18-15-
|
||||
| InChIKey |
AEHHXKHHRMBYLD-SDXDJHTJSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [529432] | |
| NetPath Pathway | IL4 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.